Treatment of recurrent or persistent cervical node metastases in differentiated thyroid cancer: Deceptively simple options

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 8, 2012, Pages 2623-2625

  Burman, Kenneth D ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; IODINE 131; RADIOACTIVE IODINE; THYROGLOBULIN;

CANCER INVASION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER REGRESSION; CERVICAL LYMPH NODE; DIFFERENTIATED THYROID CANCER; DISEASE FREE SURVIVAL; DISTANT METASTASIS; EDITORIAL; HOARSENESS; HUMAN; HYPOPARATHYROIDISM; LYMPH NODE METASTASIS; MEDIASTINUM LYMPH NODE; NECK DISSECTION; NECK PAIN; PRIORITY JOURNAL; RECURRENT CANCER; SCLEROSIS; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TISSUE SCLEROSIS;

FEMALE; HUMANS; LYMPH NODES; MALE; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 84864822214     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2480     Document Type: Editorial

References (18)

1. Schuff KG 2011 Management of recurrent/persistent papillary thyroid carcinoma: efficacy of the surgical option. J Clin Endocrinol Metab 96:2038-2039
2. Mazzaferri EL, Kloos RT 2001 Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86:1447-1463 (Pubitemid 32374886)
3. Cooper DS, Doherty GM, Haugen BR, Hauger BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214
4. Chiang AC, Massagué J 2008 Molecular basis of metastasis.NEngl J Med 359:2814-2823
5. Norton L, Massagué J 2006 Is cancer a disease of self-seeding? Nat Med 12:875-878 (Pubitemid 44175132)
6. Robenshtok E, Fish S, Bach A, Domínguez JM, Shaha A, Tuttle RM 2012 Suspicious cervical lymph nodes detected after thyroidectomy for papillary thyroid cancer usually remain stable over years in properly selected patients. J Clin Endocrinol Metab 97:2706-2713
7. Rondeau G, Fish S, Hann LE, Fagin JA, Tuttle RM 2011 Ultrasono- graphically detected small thyroid bed nodules identified after total thyroidectomy for differentiated thyroid cancer seldom show clinically significant structural progression. Thyroid 21:845-853
8. Mazzaferri EL, Jhiang SM 1994 Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418-428 (Pubitemid 24345593)
9. Ito Y, Higashiyama T, Takamura Y, Kobayashi K, Miya A, Miyauchi A 2011 Prognosis of patients with papillary thyroid carcinoma showing postoperative recurrence to the central neck. World J Surg 35:767-772
10. Al-Saif O, Farrar WB, Bloomston M, Porter K, Ringel MD, Kloos RT 2010 Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer. J Clin Endocrinol Metab 95:2187-2194
11. Yim JH, Kim WB, Kim EY, Kim WG, Kim TY, Ryu JS, Gong G, Hong SJ, Shong YK 2011 The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation. J Clin Endocrinol Metab 96:2049-2056
12. Clayman GL, Shellenberger TD, Ginsberg LE, Edeiken BS, El-Naggar AK, Sellin RV, Waguespack SG, Roberts DB, Mishra A, Sherman SI 2009 Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma. Head Neck 31:1152-1163
13. Schuff KG, Weber SM, Givi B, Samuels MH, Andersen PE, Cohen JI 2008 Efficacy of nodal dissection for treatment of persistent/recurrent papillary thyroid cancer. Laryngoscope 118:768-775 (Pubitemid 351631273)
14. Jonklaas J, Sarlis NJ, Litofsky D, Ain KB, Bigos ST, Brierley JD, Cooper DS, Haugen BR, Ladenson PW, Magner J, Robbins J, Ross DS, Skarulis M, Maxon HR, Sherman SI 2006 Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid 16:1229-1242 (Pubitemid 46080167)
15. Yim JH, Kim WB, Kim EY, Kim WG, Kim TY, Ryu JS, Moon DH, Sung TY, Yoon JH, Kim SC, Hong SJ, Shong YK 2011 Adjuvant radioactive therapy after reoperation for locoregionally recurrent papillary thyroid cancer in patients who initially underwent total thyroidectomy and high-dose remnant ablation. J Clin Endocrinol Metab 96:3695-3700
16. Hay ID, Charboneau JW 2011 The coming of age of ultrasound-guided percutaneous ethanol ablation of selected neck nodal metastases in well-differentiated thyroid carcinoma. J Clin Endocrinol Metab 96:2717-2720
17. Lewis BD, Hay ID, Charboneau JW, McIver B, Reading CC, Goellner JR 2002 Percutaneous ethanol injection for treatment of cervical lymph node metastases in patients with papillary thyroid carcinoma. AJR Am J Roentgenol 178:699-704 (Pubitemid 34178153)
18. Heilo A, Sigstad E, Fagerlid KH, Håskjold OI, Grøholt KK, Berner A, Bjøro T, Jørgensen LH 2011 Efficacy of ultrasound-guided percutaneous ethanol injection treatment in patients with a limited number of metastatic cervical lymph nodes from papillary thyroid carcinoma. J Clin Endocrinol Metab 96:2750-2755